# A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

> **NCT02481947** · PHASE3 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 459 (actual)

## Conditions studied

- Chronic Idiopathic Constipation

## Interventions

- **DRUG:** BLI400 Laxative
- **DRUG:** Lubiprostone

## Key facts

- **NCT ID:** NCT02481947
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 459 (ACTUAL)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02481947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02481947, "A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02481947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*